Abstract
An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevated non-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Current Vascular Pharmacology |
| Vol/bind | 9 |
| Udgave nummer | 3 |
| Sider (fra-til) | 258-70 |
| Antal sider | 13 |
| ISSN | 1570-1611 |
| Status | Udgivet - 2011 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS